| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Endocrinology, Vol 129, 1784-1790, Copyright © 1991 by Endocrine Society
ARTICLES |
WE Rainey, K Oka, RR Magness and JI Mason
Department of Obstetrics and Gynecology, University of Texas Southwestern Medical Center, Dallas 75235-9032.
An increase in cortisol production by the fetal adrenal cortex is an important prepartum event. The increase in ovine fetal adrenal synthesis of cortisol appears to rely in part on the ACTH induction of 17 alpha-hydroxylase cytochrome P-450 (P-45017 alpha) which occurs before parturition. In the present study we examined the effect of ACTH treatment on cortisol production and P-450(17) alpha expression using primary cultures of ovine fetal adrenal cells. In addition, we examined the effects of angiotensin II (A-II) and transforming growth factor- beta (TGF beta) on ACTH-treated cells. We have demonstrated previously that these factors modulate P-450(17 alpha) levels in adult ovine and bovine adrenal cells. Fetal ovine adrenal cells were isolated from 126- to 130-day fetuses (term = 144 +/- 3 days) and placed in monolayer cell culture. After 1 day in culture the cells were treated with ACTH (10 nM) with or without A-II (0.1-100 nM) or TGF beta (1-100 pM). Medium content of cortisol was low under basal conditions, whereas ACTH- stimulated cortisol production by 10- to 100-fold. A-II and TGF beta inhibited ACTH-induced cortisol production by 70-90%. In addition, 3 days of treatment with ACTH caused a greater than 10-fold induction of P-45017 alpha enzyme activity in fetal adrenal cells. A-II and TGF beta inhibited the ability of ACTH to induce P-45017 alpha activity by at least 75%. Using an antibody to P-45017 and immunoblotting techniques the effects of ACTH, A-II, and TGF beta on enzyme activity were observed to correspond to cellular levels of P-45017 alpha protein. The inhibitory effects of TGF beta and A-II could not be overcome by the cAMP analog (Bu)2cAMP. Interestingly, the expression of the enzyme 3 beta-hydroxysteroid dehydrogenase was much less sensitive to inhibition by A-II or TGF beta. The ability of A-II and TGF beta to suppress P- 45017 alpha expression could play a role in determining the pathway of steroidogenesis and specifically the amount of cortisol produced by fetal adrenocortical cells in vivo.
This article has been cited by other articles:
![]() |
S. Gentili, J. S. Schwartz, M. J. Waters, and I. C. McMillen Prolactin and the expression of suppressor of cytokine signaling-3 in the sheep adrenal gland before birth Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2006; 291(5): R1399 - R1405. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Wang, N. K. Valego, Y. Su, J. Smith, and J. C. Rose Developmental Aspects of Ovine Adrenal Adrenocorticotropic Hormone Receptor Expression Reproductive Sciences, January 1, 2004; 11(1): 27 - 35. [Abstract] [PDF] |
||||
![]() |
X. Yan, J.-F. Mouillet, Q. Ou, and Y. Sadovsky A Novel Domain within the DEAD-Box Protein DP103 Is Essential for Transcriptional Repression and Helicase Activity Mol. Cell. Biol., January 1, 2003; 23(1): 414 - 423. [Abstract] [Full Text] |
||||
![]() |
E. Chamoux, A. Narcy, J.-G. Lehoux, and N. Gallo-Payet Fibronectin, Laminin, and Collagen IV as Modulators of Cell Behavior during Adrenal Gland Development in the Human Fetus J. Clin. Endocrinol. Metab., April 1, 2002; 87(4): 1819 - 1828. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R.G. Challis, S. G. Matthews, W. Gibb, and S. J. Lye Endocrine and Paracrine Regulation of Birth at Term and Preterm Endocr. Rev., October 1, 2000; 21(5): 514 - 550. [Abstract] [Full Text] |
||||
![]() |
C. Le Roy, J. Y. Li, D. M. Stocco, D. Langlois, and J. M. Saez Regulation by Adrenocorticotropin (ACTH), Angiotensin II, Transforming Growth Factor-{beta}, and Insulin-Like Growth Factor I of Bovine Adrenal Cell Steroidogenic Capacity and Expression of ACTH Receptor, Steroidogenic Acute Regulatory Protein, Cytochrome P450c17, and 3{beta}-Hydroxysteroid Dehydrogenase Endocrinology, May 1, 2000; 141(5): 1599 - 1607. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. L. Coulter, D. A. Myers, P. W. Nathanielsz, and I. M. Bird Ontogeny of Angiotensin II Type 1 Receptor and Cytochrome P450c11 in the Sheep Adrenal Gland Biol Reprod, March 1, 2000; 62(3): 714 - 719. [Abstract] [Full Text] |
||||
![]() |
K. R. Poore, I. R. Young, B. J. Canny, and G. D. Thorburn Angiotensin II infusion in vivo does not modulate cortisol secretion in the late-gestation ovine fetus Am J Physiol Regulatory Integrative Comp Physiol, August 1, 1998; 275(2): R357 - R362. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. M. Bird, J. I. Mason, and W. E. Rainey Protein Kinase A, Protein Kinase C, and Ca2+-Regulated Expression of 21-Hydroxylase Cytochrome P450 in H295R Human Adrenocortical Cells J. Clin. Endocrinol. Metab., May 1, 1998; 83(5): 1592 - 1597. [Abstract] [Full Text] |
||||
![]() |
I. M. Bird, R. A. Word, C. Clyne, J. I. Mason, and W. E. Rainey Potassium Negatively Regulates Angiotensin II Type 1 Receptor Expression in Human Adrenocortical H295R Cells Hypertension, June 1, 1995; 25(6): 1129 - 1134. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |